Donald W Landry

USPTO Granted Patents = 84 (Patent Applications = 39)

CIPO Patents = 5 (Patent Applications = 8)

EPO Patents = 22 (Patent Applications = 33)

Average Co-Inventor Count = 3.3

ph-index = 8

Forward Citations = 273(Granted Patents)

Forward Citations (Not Self Cited) = 192(Dec 10, 2025)

Inventors with similar research interests:

Location History:

South New York, NY (US) (1999)
New York, NY (US) (1995 - 2024)

Company Filing History:

Ny State Psychiatric Institute

patents

4 out of 3,384

University of Michigan

patents

4. 3 out of 881

University of Kentucky Research Foundation

patents

5. 2 out of 290

Les Laboratoires Servier

Janus Pharmaceuticals, Inc.

patent

8. 1 out of 1

Intradialytic Pharmaceuticals

patent

9. 1 out of 504

Albert Einstein College of Medicine

11. 1 out of 832,880

Other

patents

where one patent can have more than one assignee

Years Active: 1995-2025

Loading Chart...

Areas of Expertise:

Histone Acetyltransferase Activators

Aldose Reductase Inhibitors

Phosphodiesterase Inhibitors

T-Cell Acute Lymphoblastic Leukemia

Autophagic Flux Activators

Cocaine Esterase Mutants

Neuronal Pain Pathway

Cancer Treatment Compounds

Proteinopathies Treatment

Hypoglycemic Dihydropyridones

Anti-Drug Vaccines

Glucose Metabolism Modulators

84 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12492207 - Compounds, pharmaceutical formulations, and methods for treatment of cancer (2025-12-09),

2. 12239618 - Histone acetyltransferase activators and compositions and uses thereof (2025-03-04),

3. 12168664 - Triazolopyrimidines, their preparation and use (2024-12-17),

4. 12077547 - Aldose reductase inhibitors and methods of use thereof (2024-09-03),

5. 11851427 - Phosphodiesterase inhibitors and uses thereof (2023-12-26),

6. 11730737 - Aldose reductase inhibitors and uses thereof (2023-08-22),

7. 11529349 - Aldose reductase inhibitors and uses thereof (2022-12-20),

8. 11498925 - Aldose reductase inhibitors and methods of use thereof (2022-11-15),

9. 11459306 - Compounds, compositions, and methods for treating T-cell acute lymphoblastic leukemia (2022-10-04),

10. 11406608 - Histone acetyltransferase activators and compositions and uses thereof (2022-08-09),

11. 11261199 - Activators of autophagic flux and phospholipase d and clearance of protein aggregates including tau and treatment of proteinopathies (2022-03-01),

12. 11230558 - Activators of autophagic flux and phospholipase D and clearance of protein aggregates including tau and treatment of proteinopathies (2022-01-25),

13. 11191768 - Histone acetyltransferase activators and uses thereof (2021-12-07),

14. 11098296 - Mutants of cocaine esterase (2021-08-24),

15. 11034647 - Histone acetyltransferase activators and uses thereof (2021-06-15),

Title: The Innovative Journey of Donald W. Landry

Introduction: Donald W. Landry, a pioneering inventor based in New York, NY, has made significant contributions to the field of innovations and patents with his groundbreaking work.

Latest Patents: Donald W. Landry holds several patents in various industries, showcasing his diverse range of expertise and innovative mindset.

Career Highlights: Throughout his illustrious career, Donald W. Landry has been at the forefront of cutting-edge inventions, revolutionizing the way we approach challenges and solutions in different sectors.

Collaborations: Donald W. Landry has collaborated with leading experts, companies, and research institutions, further solidifying his reputation as a visionary inventor with a collaborative spirit.

Conclusion: Donald W. Landry's relentless pursuit of innovation and his remarkable contributions to the world of patents make him a true trailblazer in the field, inspiring future generations of inventors to push the boundaries of what is possible.

This text is generated by artificial intelligence and may not be accurate.